Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by the Cell of Origin
Mechanistically, these findings suggest that most of the DLBCL risk factors evaluated here influence lymphomagenesis prior to differentiation into COO subtypes, with selected factors acting later.
Authors
- Lisa M. Rimsza (ORCID: https://orcid.org/0000-0003-1268-2750)
- Rebecca L. King (ORCID: https://orcid.org/0000-0002-7132-0226)
- Carrie A. Thompson (ORCID: https://orcid.org/0000-0002-4518-2309)
- Thomas Matthew Habermann (ORCID: https://orcid.org/0000-0003-3532-9132)
- Anne J. Novak (ORCID: https://orcid.org/0000-0002-7904-1651)
- Geffen Kleinstern (ORCID: https://orcid.org/0000-0001-6148-0421)
- Matthew J. Maurer (ORCID: https://orcid.org/0000-0002-1867-0526)
- Stephen M. Ansell (ORCID: https://orcid.org/0000-0003-1244-6758)
- Grzegorz S. Nowakowski (ORCID: https://orcid.org/0000-0002-6955-9393)
- Susan L. Slager (ORCID: https://orcid.org/0000-0002-5173-4712)
- James R. Cerhan (ORCID: https://orcid.org/0000-0002-7482-178X)
- Andrew L. Feldman (ORCID: https://orcid.org/0000-0001-5009-4808)
- Melissa C. Larson (ORCID: https://orcid.org/0000-0002-5430-8161)
- Dennis P. Robinson (ORCID: https://orcid.org/0009-0000-4812-9397)
Institutions
- Mayo Clinic (US)
- University of Arizona (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- University of Haifa (IL)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1158/1055-9965.epi-24-1610
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00